Introduction
The reported incidence of neoplastic disease in the extinct human lineage is rare. Only a few confirmed cases of Middle or Later Pleistocene dates (780 000 to 120 000 years old) have been reported. 1, 2 It is generally assumed that pre-modern incidence of neoplastic disease of any kind is rare and limited to benign conditions, but new fossil evidence suggests this is not so. We here present the earliest identifiable case of malignant neoplastic disease from an early human ancestor dated to 1.8-1.6 million years old (Ma). The diagnosis is possible only because of advances in 3D imaging methods as an aid in diagnosis.
A neoplasm ('new-growth' or tumour) is defined as a mass of localised tissue growth in which cellular proliferation is no longer subject to the effects of normal growth-regulating mechanisms.
1,2 A tumour may be benign or malignant in nature; malignant tumours are often colloquially referred to as a cancer. 3 Malignancy is the primary cause of death in industrialised countries and the second foremost cause of death in developing countries. 4, 5 Since 1999, malignancy has surpassed cardiac disease as the leading cause of death for humans younger than 85 years in the USA 6 , and is often perceived to be a disease of modernity [7] [8] [9] . At present, true neoplastic diseases seem to be restricted to complex vertebrate animals. Only one observation of true malignancy has been described in one of the simpler living vertebrates, specifically hepatomas in the cartilaginous skeleton of the jawless hagfish. 2 This is a very important case for the comparative pathology of malignancy, because lampreys are among the simplest living vertebrates.
The fact that malignancy has great antiquity is demonstrated from the fossil record. The earliest definitive evidence for neoplastic disease comes from pre-Cenozoic contexts, with purported cases of neoplasm found in fossil fish from the Upper Devonian. The earliest unequivocal case dates from 300 Ma, with evidence of benign osteoma with focal hyperostosis affecting a partial skeleton of the fish Phanerosteon mirabile from the North American Lower Carboniferous. 2 Later cases include diagnoses of benign haemangioma and eosinophilic granuloma in Jurassic dinosaurs; benign osteoma in mosasaurs; and haemangioma, metastatic disease, desmoplastic fibroma, and osteoblastoma in Cretaceous hadrosaurs. 10, 11 Benign osteoid osteoma and osteoblastoma have been identified in European mammoths dating from 24 to 23 thousand years ago (ka). 12 Evidence for neoplastic disease is not unknown in the human fossil, archaeological and historical records, 1, 3, 13 but is generally considered rare. Historically, the earliest fossil evidence for neoplastic disease in the human lineage was suggested to be from a mandible of archaic Homo from Kanam in Kenya. This lesion has variously been attributed to osteosarcoma, bone keloid, Burkitt's lymphoma, or traumatic osteomyelitis.
2,14-17 The first substantive evidence for hominin neoplastic disease is derived from a juvenile skeleton of Australopithecus sediba, dated to 1.98 Ma, from the site of Malapa in South Africa. An invasive spinal lesion has been attributed by Randolph-Quinney and colleagues to benign osteoid osteoma, a non-malignant tumour. 18 Later significant evidence for near-human neoplastic disease is suggested by Monge and colleagues 19 , who present a case of fibrous dysplasia from a Neanderthal rib dated to 120 000 ka from the site of Krapina.
Here we present the earliest fossil evidence for malignant neoplastic disease in the hominin record, with a detailed description and differential diagnosis of malignant osteosarcoma. Our report is based on reanalysis of a hominin metatarsal specimen (SK 7923) (gen. et spec. indet.) from the cave site of Swartkrans in the Cradle of Humankind, South Africa. SK 7923 is a metatarsal recovered from the Member 1 Hanging Remnant, which has yielded fossils of both Homo ergaster and Paranthropus robustus. 20 Several faunal estimates have indicated the age of the Hanging Remnant at between 1.5 Ma and 1.8 Ma. [21] [22] [23] Recent electron spin resonance dating has estimated the age of the Hanging Remnant of Swartkrans at 1.6 Ma. 24 The oldest southern African specimens of early Homo and Paranthropus present around 2.1-1.9 Ma in Member 1, and are recorded until around 1.0-0.6 Ma in Member 3 of the Swartkrans cave.
Swartkrans hominin site
Swartkrans was discovered in 1948. The site is situated approximately 40 km northwest of Johannesburg, on the bank of the Blaauwbank River in the province of Gauteng, South Africa. It is arguably one of the most important palaeocave sites in southern Africa, if not globally, and is best known for its rich heritage of Paranthropus robustus fossils, and purported evidence for early hominin use of controlled pyrotechnology. During much of their early research, Broom and his assistant Robinson excavated a considerable sample of hominin remains attributable to Paranthropus robustus and Homo from the site. 26, 27 Swartkrans was the first site where these two genera of hominins were considered to be contemporary.
After an approximately 12-year hiatus of non-activity, Brain's subsequent excavations at Swartkrans from the mid-1960s to the mid-1980s produced a significant addition to the faunal 20 , fossil and archaeological collection. From the total number of specimens obtained at the Swartkrans site, 415 accessioned specimens are identified as hominin. 20 Brain's work demonstrated that the stratigraphy of the site was much more complex than originally posited. Brain subsequently demonstrated five members at Swartkrans. 22 Member 1 consists of two distinct masses, the Hanging Remnant and Lower Bank 22 , each of them yielding Homo ergaster and Paranthropus robustus 28 . Homo and Paranthropus have been discovered from Member 2.
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SK 7923 case study
SK 7923 is a left 5th metatarsal, preserving the proximal diaphysis and much of the distal portion, but lacking the articular end. The specimen is hominin, but cannot be allocated to a specific taxon. Pathologically, SK 7923 presents a growth on the proximo-ventral aspect of the shaft. Here, an irregular hemi-spherical mass abuts the cortex (Figure 1 ), measuring 5.2 mm x 4.7 mm. The specimen was originally studied as part of an unpublished doctoral thesis, where the morphology led one of us (R.F.) to diagnose osteoid osteoma. However, recent internal imaging has led to a re-evaluation of the pathology.
The bone was examined using micro-focus X-ray computed tomography (µXCT) at the South African Nuclear Centre for Radiography and Tomography (located at the South African Nuclear Energy Corporation, NECSA). The bone was scanned by F.d.B. and J.W.H. using a Nikon XTH225ST µXCT system, at an energy potential of 100 kV and resolution of 17 microns. Reconstruction was performed by E.J.O. and P.R.Q. using Avizo Amira 5.4 to generate both 2D orthoslice and 3D surface rendered views. The cross-section shows that the hemispherical mass is not fully fused to or integrated with the cortex, but adheres to the bone surface, displaying an irregular spongy woven bone texture with a cauliflower-like external appearance (Figure 2a) . The cortical bone directly underlying the mass is covered with a thin layer of new woven bone, with a Codman triangle displayed at the margins. The texture is granular and exhibits ellipsoid lytic lesions in transverse view. There is localised sub-periosteal invasion by the mass into the cortex (Figure 2a) . Surprisingly, µXCT showed much of the medullary cavity to be infilled with bone, with clear internal remodelling and de-novo bone formation (Figure 2b ). Inside the cortex are several irregular and large circular voids, caused by bony encapsulation of normal vascular channelling found within the endosteal surface of the medullary cavity. The remaining medullary space is obliterated by new bone growth.
A number of bone-forming conditions should be considered in the differential diagnosis: chondrosarcoma, Ewing's sarcoma, metastatic carcinoma, osteochondroma, osteoblastoma and osteosarcoma (see Supplementary Appendix for a more detailed breakdown). 3, [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] Osteosarcoma usually starts in the medulla and characteristically arises within the metaphysis of long bones, growing circumferentially through the cortex into soft tissue and raising the periosteum. This seems to have occurred in SK 7923, with a Codman triangle visible. Osteosarcoma (osteogenic sarcoma) prefers fast-growing regions and usually occurs around the knee. It presents in metatarsals in less than 1% of clinical cases. According to Vigorita 47 , the periosteal reaction may have a 'sunburst' appearance, which is to some extent visible in Figure 2a . Given the internal and external morphology of this specimen, it seems most likely that this pathology is attributable to osteosarcoma, with a strong possibility of the parosteal variant of this condition. Diagnosis was supported by µXCT imaging of a modern clinically diagnosed case of osteosarcoma of the distal femur. Comparison of Figures 2b and 2c shows clear similarities between the appearance of the fossil and modern medullary infills.
Osteosarcoma is a primary malignant tumour that typically exhibits cortical and medullary disruption and some degree of mineralisation. It also typically shows aggressive periosteal new bone reaction, which can include either lamination, Codman triangle, or spiculated sunburst reaction. The most common form is central osteogenic sarcoma, which could be osteoblastic or osteolytic in nature, or both. This typically occurs in the metaphyseal and diaphyseal area of the major long bones. Parosteal osteosarcoma is the most common type of juxtacortical or surface osteosarcoma. This often presents as a lobulated 'cauliflower' mass with central ossification adjacent to the bone, and may infiltrate the bone marrow. Bone destruction is rare, but when present is regional. http://www.sajs.co.za
Volume 112 | Number 7/8 July/August 2016
Most parosteal osteosarcomas are found in the metaphyseal region of long tubular bones. The most common site is the distal femur, followed by the upper shaft of the tibia, and then the proximal humerus.
Functionally, this malignancy may have presented secondary consequences in our case study. The belly of abductor digitii minimi may have been displaced laterally, and with fibularis brevis and f. tertius inserting just proximal and distal to the growth, some influence on gait was likely. The presence of sub-periosteal bone formation in the form of a Codman triangle, cortical invasion, spiculated mass abutting the exosteum, and aggressive medullary infilling (including the combination of trabeculated and avascular bone) indicates that what was originally diagnosed as a benign exosteal growth is now shown to represent a malignant bone malignancy. This change in diagnosis is entirely the result of advances in high-resolution 3D imaging, together with the judicious use of comparative clinical pathology. It is thus possible that cases of malignancy might remain unknown in fossil assemblages awaiting imaging and discovery.
Discussion
This case highlights a significant issue with regard to modern clinical incidence and expression of neoplastic disease, and malignancy in particular. That is, how can we understand ancient disease evolution when sample sizes are extremely small? As noted above [7] [8] [9] , malignancy is perceived as a disease of modernity. However, it is worth noting that primary skeletal malignant tumours are not commonly encountered in the modern clinical environment, and although rare they do feature in the archaeological and fossil record 3, 18 . Historically, factors of preservation have limited the study of human neoplasia to the skeleton, from which the confident diagnosis of tumours has been problematical. 48 Recent work on artificially mummified Egyptian remains has suggested to some scholars 9, 49 that malignancy was almost absent in pre-modern human populations. For example, Gray 49 reported no radiological confirmation of malignant neoplasia among 193 examined Egyptian mummies. However, we view this assertion as tautological, because the samples on which the claim is based are not representative of the bulk of the human species living in antiquity; they represent only a small fraction of all humans living at that time 50 . From the global historical sample available to us for study, malignancy does exist, albeit rarely -and a subset of those cases include osteosarcoma. Probable pre-modern cases are reported from Hawaii 51 , the Czech Republic 52 , and the Peruvian Andes 1 .
The precise range of causes underlying malignancies is still largely unknown. Where causes have been established, these are generally understood to fall into three categories: physical, chemical, and viral. 1 Physical causes include being exposed to ultraviolet light (which increases the risk of basal cell carcinoma and malignant melanoma) and levels of background radiation. 1 Causative examples in the historical modern environment include the effects of radiation from the dropping of atomic bombs on Japan during World War II, which has been linked to an escalation in myelogenous leukaemia and thyroidal malignancy. 1 Chemical carcinogens in humans have historically been known to target skin and lungs, urinary bladder, and nasal sinuses and pleura. Potts demonstrated a relationship between scrotal malignancy in chimney sweepers and exposure to soot as early as 1775. 53 Many chemicals are widely accepted to be carcinogenic. Radon from granite, for example, is a radioactive gas causing lung malignancy. 1 Several viruses can cause malignancy in animals, and the association of some viruses with human malignancy is considerable. Examples include human papilloma virus (cervix malignancy), hepatitis B or C virus (liver malignancy), EpsteinBarr virus (non-Hodgkin lymphomas and nasopharyngeal malignancy), and human immunodeficiency virus (linked to non-Hodgkin lymphoma and Kaposi sarcoma). 1 Whilst most modern human malignancies are thought to be caused by environmental agents of a chemical nature, the evidence for this is not entirely conclusive. 1,p.373 The internal environment, namely diet and lifestyle, is thought to play a significant role in malignancy disposition. Some malignancies are certainly triggered by modern lifestyle factors, such as smoking, drinking (which can lead to liver and oesophageal malignancy), sunbathing, and obesity (which can lead to gastrointestinal gut malignancy). 1 Pesticides and industrial chemicals can cause malignancy, but their contribution is thought to be relatively minor. Of perhaps greatest impact is colorectal malignancy, which kills approximately 700 000 people every year worldwide 8 , and is most prevalent in developed countries such as USA and Europe. The lowest incidence occurs in underdeveloped countries in Africa, which have vastly different dietary regimes available to the population. Brody 8 has named colorectal cancer a disease of modernity and development. In other words, economic growth is associated with a rise in the incidence of colorectal malignancy, with corresponding lifestyle changes possibly playing a strong role in the prevalence of this disease. An example is China, where a marked increase in the prevalence of colorectal malignancy is occurring. 8 In addition, whilst the modern lifestyles of humans may enhance the frequency of cancer, longer life expectancies mean malignancy would logically occur at a higher rate among modern people than in our prehistory. We are unable to assess the age at death of the Swartkrans SK 7923 hominin (other than skeletally adult), but it was likely to have been substantially less than modern life expectancy, based on demographic studies of early hominin taxa 54 .
The expression of malignant osteosarcoma in the Swartkrans SK 7923 specimen indicates that whilst the explosion of malignancy incidence is clearly correlated with the hazards of the modern world and increased life expectancy, primary bone tumours evidently occurred throughout history. Then, as now, such tumours would have occurred predominantly in younger individuals. Neoplastic disease has considerable antiquity, as evidenced by this specimen and further supported by numerous published case studies of benign neoplasms with deep antiquity in the fossil record, as noted above. [1] [2] [3] [10] [11] [12] 18, 55, 56 The theory that the almost total lack of malignancies in Egyptian mummies indicates that the disease occurs only in industrialised societies 9 is thus questionable.
The lack of substantial evidence of malignancy in the fossil and bioarchaeological records might arguably be an artefact of preservation, or of sampling bias and tiny sample sizes, or of analytical techniques or the application of inefficient imaging modalities 57 . For example, the results would differ if plain radiography or clinical magnetic resonance imaging are used rather than micro-computed tomography. The absolutely small sample sizes arise from short life expectancy among pre-modern societies. Hence, the rare incidence of cancer cases found in the record can be seen as most likely non-representative, and should not be construed as indicating the true prevalence of disease. It is important to note that because of the worldwide demographic transition and average increased age at death for humans, non-primary bone malignancy can be expected to occur at a higher rate today than in pretransition populations. 50 As highlighted in the introduction, malignancy occurs in almost all metazoans, suggesting that the mechanisms of malignancy have an extremely old evolutionary history. For example, neoplasms have been recorded in dinosaurs and other fossil forebears. 2, 11, 56 A number of oncogenes are particularly archaic, with their antecedents exhibited in some form in primitive common ancestor metazoans of chordates and arthropods. 55, 58 Thus, the capacity for malignancy is ancient, and the higher incidence of malignancy in today's developed and developing world may be related to the unique interaction between environmental factors -which have no parallel in prehistory 59 . It is also important to note that modern non-invasive imaging techniques (such as micro-computed tomography or phase-contrast synchrotron tomography), together with the appropriate use of clinical homologues, play a considerable role in enabling accurate diagnoses. These new techniques hold considerable potential for re-investigating previously reported palaeopathological lesions.
